Search Results for “Look Forward” - Page 9

Gene Therapy improves functional measures in XLRP

Beacon Therapeutics announced positive results from their phase 2 gene therapy trial for X-linked retinitis pigmentosa (XLRP) caused by mutations in the RPGR gene.

New ‘vision’ and identity sight loss charities

The collective partnership of eight of the leading charities in the sight loss sector, known for the last three years as the VI Charity Sector Partnership, has re-launched under a new identity of the ‘Vision Partnership’ with a re-invigorated purpose and new strategic focus.

News

A young girl wearing sunglasses and a Retina UK t-shirt.

Rose Earnshaw: An inspirational 8-year-old’s epic challenge

In August 2025, 8-year-old Rose Earnshaw is taking on a challenge like no other – completing 5 laps of her local village park (1 mile) every day throughout the month of August, in support of Retina UK’s vital work.

The molecular map of congenital stationary night blindness – the science of seeing in the dark

A recently published study has provided the first molecular map of the mutation-specific changes that occur in the retina which lead to Congenital Stationary Night Blindness.

News

New nanoparticle gene therapy research provides hope for treating inherited sight loss

Researchers from Ghent University have published a study that has the potential to transform inherited retinal disease (IRD) treatment development.

Exciting developments for new treatment research

In recent years there has, understandably, been a lot of excitement around cutting-edge therapies that target the specific genetic faults underlying inherited sight loss.

News

Meet a Researcher: Elena Piotter

Nurturing a new generation of scientists is a vital investment in the future of retinal disease research, so we are delighted to be funding, in collaboration with the Macular Society, a new PhD studentship at Oxford University, supervised by Professor Robert MacLaren.

Helpline

Search